NTRB

MKT CAP:$43M

Nutriband Inc

Market Cap

$43M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.05-$1.38 (-31.15%)

Jul 15, 2026

52W High $8.8152W Low $2.90

Company Details

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA bupr...

Leadership

Serguei MelnikFounder

Founder, President, Company Secretary & Executive Chairman

Gareth SheridanFounder

Founder, CEO & Director

Gerald Goodman

CFO & Chief Accounting Officer

Alan Smith Ph.D.

COO & President of 4P Therapeutics

Jeffrey Patrick Pharm.D.

Chief Scientific Officer

Michael Myer

President of Pocono Pharmaceutical

Tyler Overk

Head of Active Intelligence

IPO Date

Nov 30, 2017

Website

www.nutriband.com

Key Metrics TTM

Revenue

$2M

-4.8% YoY

Net Income

-$8M

EPS (Diluted)

Free Cash Flow

-$5M

Revenue / Share

Gross Margin

24.9%

Operating Margin

-408.4%

Net Margin

-404.1%

FCF Margin

-251.9%

P/S

21.2x

P/E

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Revenue by Geography

Revenue by Product

War Chest